(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33%.
Sana Biotechnology's earnings in 2026 is -$149,269,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$189,998,522, with the lowest SANA earnings forecast at -$205,549,576, and the highest SANA earnings forecast at -$125,846,679. On average, 12 Wall Street analysts forecast SANA's earnings for 2027 to be -$164,829,187, with the lowest SANA earnings forecast at -$196,740,309, and the highest SANA earnings forecast at -$81,800,342.
In 2028, SANA is forecast to generate -$173,488,637 in earnings, with the lowest earnings forecast at -$220,231,689 and the highest earnings forecast at -$78,654,175.